Skip to main content
. 2013 Nov;195(21):4854–4864. doi: 10.1128/JB.00779-13

Table 2.

Negative-ion CE-ES-MS data and proposed compositions of O-deacylated LPS (LPS-OH) and core OS from the Heddleston serovar 3 and 4 type strains (P1059 and P1662), and proposed compositions of LPS-OH from the P1059 TargeTron mutants

Study and serovar (description) Observed ions (m/z)
Molecular mass (Da)a
Relative intensity Proposed composition
(M − H) (M − 4H)4− (M − 3H)3− (M − 2H)2− Observed Calculated
Serovar study
    Serovar 3 (P1059) 1,106.5 3,322 3,320.0 0.2 HexNAc, 6Hex, 4Hep, Kdo-P, PEtn, lipid A-OH
        LPS-OH 1,147.3 1,721.2 3,444 3,443.0 1.0 HexNAc, 6Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
889.8 1,188.2 3,568 3,566.0 0.8 HexNAc, 6Hex, 4Hep, Kdo-P, 3PEtn, lipid A-OH
    Serovar 4 (P1662)
        LPS-OH 707.4 943.5 2,833.6 2,831.6 0.2 5Hex, 4Hep, Kdo-P, lipid A-OH
738.0 984.3 1,477.2 2,956.0 2,954.7 0.5 5Hex, 4Hep, Kdo-P, PEtn, lipid A-OH
768.6 1,025.4 1,538.7 3,079.0 3,077.7 1.0 5Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
799.5 1,066.2 3,202.2 3,200.7 0.5 5Hex, 4Hep, Kdo-P, 3PEtn, lipid A-OH
        Core OS 899.1 1,800.2 1,799.5 0.2 5Hex, 4Hep, aKdob
960.3 1,922.6 1,922.6 0.8 5Hex, 4Hep, PEtn, aKdob
1,022.1 2,046.2 2,045.7 1.0 5Hex, 4Hep, 2PEtn, aKdob
GctC study
    AL539
        LPS-OH (gatA polar mutant) 709.7 1,064.9 2,131.9 2,130.9 0.2 Hex, 3Hep, 2Kdo, lipid A-OH
717.0 1,075.9 2,153.9 2,152.9 1.0 2Hex, 3Hep, Kdo-P, lipid A-OH
        LPS-OH 758.0 1,137.4 2,276.9 2,276.0 0.6 2Hex, 3Hep, Kdo-P, PEtn, lipid A-OH
773.5 1,160.9 2,323.7 2,323.1 0.1 Hex, 4Hep, 2Kdo, lipid A-OH
780.5 1,171.5 2,344.8 2,345.1 0.2 2Hex, 4Hep, Kdo-P, lipid A-OH
822.1 1,233.2 2,469.2 2,468.2 0.1 2Hex, 4Hep, Kdo-P, PEtn, lipid A-OH
    AL806 LPS-OH (AL539 + gctC, hptE) 691.8 923.2 2,772.1 2,770.5 0.5 3Hex, 4Hep, 2Kdo, PEtn, lipid A-OH
930.4 2,794.2 2,792.4 0.3 4Hex, 4Hep, Kdo-P, PEtn, lipid A-OH
728.5 971.4 2,917.6 2,915.5 1.0 4Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
GatF study
    AL2116 LPS-OH (gatF mutant) 697.7 930.7 1,395.5 2,794.0 2,792.4 0.3 4Hex, 4Hep, Kdo-P, PEtn, lipid A-OH
728.3 971.2 1,457.2 2,916.6 2,915.5 1.0 4Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
    AL2297 LPS-OH (gatF mutant + gatF) 1,174.0 3,525.0 3,523.2 0.4 2HexNAc, 6Hex, 4Hep, Kdo-P, PEtn, lipid A-OH
1,215.0 3,648.0 3,646.3 1.0 2HexNAc, 6Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
GatG study
    AL2155 LPS-OH (gatG mutant) 768.9 1,025.3 3,079.2 3,077.7 1.0 5Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
799.6 1,066.2 3,202.0 3,200.8 1.0 5Hex, 4Hep, Kdo-P, 3PEtn, lipid A-OH
    AL2192 LPS-OH (gatG mutant + gatG) 1,106.5 3,322.5 3,320.0 1.0 HexNAc, 6Hex, 4Hep, Kdo-P, lipid A-OH
1,147.5 3,445.5 3,443.1 0.9 HexNAc, 6Hex, 4Hep, Kdo-P, lipid A-OH
1,174.0 3,525.0 3,523.2 0.3 2HexNAc, 6Hex, 4Hep, Kdo-P, PEtn, lipid A-OH
1,215.0 3,648.0 3,646.3 0.4 2HexNAc, 6Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
NatB study
    AL2117 LPS-OH (natB mutant) 768.7 1,025.4 3,079.0 3,077.7 0.8 5Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
809.4 1,079.5 3,241.5 3,239.9 1.0 6Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
    AL2299 LPS-OH (natB mutant + natB) 1,174.0 3,525.0 3,523.2 0.4 2HexNAc, 6Hex, 4Hep, Kdo-P, PEtn, lipid A-OH
1,215.0 3,648.0 3,646.3 1.0 2HexNAc, 6Hex, 4Hep, Kdo-P, 2PEtn, lipid A-OH
a

Average mass units were used for calculation of molecular mass based on the proposed composition, as follows: lipid A-OH, 952.00; Hex, 162.15; Hep, 192.17; Kdo, 220.18; anhydro Kdo (aKdo), 202.18; PEtn, 123.05; P, 79.95.

b

aKdo, hydrolysis products of Kdo formed during core hydrolysis.